These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 2734822
1. Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple red cell alloantibodies. Depalma L, Leitman SF, Carter CS, Gallin JI. Transfusion; 1989 Jun; 29(5):421-3. PubMed ID: 2734822 [Abstract] [Full Text] [Related]
2. Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils. Bryant BJ, Yau YY, Byrne PJ, Stroncek DF, Leitman SF. Transfusion; 2010 Jun; 50(6):1203-9. PubMed ID: 20113453 [Abstract] [Full Text] [Related]
3. Hydroxyethylstarch sedimentation by gravity ex vivo for red cell reduction of granulocyte apheresis components. Adkins D, Johnston M, Walsh J, Spitzer G, Goodnough T. J Clin Apher; 1998 Jun; 13(2):56-61. PubMed ID: 9704606 [Abstract] [Full Text] [Related]
4. Granulocyte transfusion therapy in chronic granulomatous disease. Report of a patient and review of the literature. Yomtovian R, Abramson J, Quie P, McCullough J. Transfusion; 1981 Jun; 21(6):739-43. PubMed ID: 7314224 [Abstract] [Full Text] [Related]
5. Transfusion-related red blood cell alloantibodies: induction and consequences. Tormey CA, Hendrickson JE. Blood; 2019 Apr 25; 133(17):1821-1830. PubMed ID: 30808636 [Abstract] [Full Text] [Related]
6. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Transfusion; 2002 Jan 25; 42(1):37-43. PubMed ID: 11896310 [Abstract] [Full Text] [Related]
7. [Advancement in the preparation of red cell concentrates and platelet concentrates]. Inaba S. Masui; 2011 Jan 25; 60(1):23-30. PubMed ID: 21348247 [Abstract] [Full Text] [Related]
8. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation. Zupańska B, Zaucha JM, Michalewska B, Malinowska A, Brojer E, Hellmann A. Transfusion; 2005 Jan 25; 45(1):16-20. PubMed ID: 15647013 [Abstract] [Full Text] [Related]
9. Hemolysis following platelet transfusions from ABO-incompatible donors. Pierce RN, Reich LM, Mayer K. Transfusion; 1985 Jan 25; 25(1):60-2. PubMed ID: 2578692 [Abstract] [Full Text] [Related]
10. The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Heim KF, Fleisher TA, Stroncek DF, Holland SM, Gallin JI, Malech HL, Leitman SF. Transfusion; 2011 Jun 25; 51(6):1154-62. PubMed ID: 21175646 [Abstract] [Full Text] [Related]
11. Alloimmunization after granulocyte transfusions. Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF. Transfusion; 1996 Jun 25; 36(11-12):1009-15. PubMed ID: 8937413 [Abstract] [Full Text] [Related]
12. Chronic granulomatous disease and the Mcleod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction. Brzica SM, Pineda AA, Taswell HF, Rhodes KH. Mayo Clin Proc; 1977 Mar 25; 52(3):153-6. PubMed ID: 839862 [Abstract] [Full Text] [Related]
13. A double buffy coat method for red cell removal from ABO-incompatible marrow. Rosenfeld CS, Tedrow H, Boegel F, Gremba C, Shadduck RK. Transfusion; 1989 Jun 25; 29(5):415-7. PubMed ID: 2660336 [Abstract] [Full Text] [Related]
14. Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis. Ikincioğullari A, Dogu F, Solaz N, Reisli I, Kemahli S, Cin S, Babacan E. Ther Apher Dial; 2005 Apr 25; 9(2):137-41. PubMed ID: 15828925 [Abstract] [Full Text] [Related]
15. Current status of leukocyte and platelet administration in cancer therapy. Walker EM, Cannon A, Mitchum EN. Ann Clin Lab Sci; 1983 Apr 25; 13(6):453-73. PubMed ID: 6197928 [Abstract] [Full Text] [Related]
16. Removal of ABO-incompatible red cells from lymphocytapheresis and granulocytapheresis components before transfusion. Wuest DL, Reich LM. Transfusion; 1997 Feb 25; 37(2):144-9. PubMed ID: 9051088 [Abstract] [Full Text] [Related]
17. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Transfus Med Rev; 2019 Jan 25; 33(1):12-23. PubMed ID: 30122266 [Abstract] [Full Text] [Related]
18. Granulocyte transfusion therapy in children. Maybee DA, Millan AP, Ruymann FB. South Med J; 1977 Mar 25; 70(3):320-4. PubMed ID: 265630 [Abstract] [Full Text] [Related]
19. Preparation and in vitro function of granulocyte concentrates for transfusion to neonates using the IBM 2991 blood processor. Goldfinger D, Medici MA, Hsi R, McPherson J, Connelly M. Transfusion; 1983 Mar 25; 23(4):358-60. PubMed ID: 6879682 [Abstract] [Full Text] [Related]